Covid-19 emergency veklury remdesivir - CI

Ended Awarded Last action

Contract number
36C26321N0248
Awardee
Awarding agency
Obligated
$81,743

Award facts

Contract value 100% obligated
$81,742.50 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Beaverdale, IA 50310, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 -$210,195
Original award $291,938

About this award

This federal contract award is a delivery order under Gilead Sciences Inc.'s General Services Administration (GSA) Schedule 61-IB contract for Pharmaceuticals and Drugs. The $81,742.50 firm fixed-price contract was awarded by the U.S. Department of Veterans Affairs (VA) for Veklury (remdesivir), an antiviral medication used to treat COVID-19. The contract has an ultimate completion date of September 30, 2021 and was not set aside for small businesses. Gilead Sciences, the prime contractor, is a prominent biopharmaceutical company that has a history of supplying critical medications to federal healthcare programs, particularly the VA. This contract award is part of Gilead's broader strategic relationship with the VA, which includes a $29.16 million Blanket Purchase Agreement for specialty medications such as Letairis, Yescarta, and Tecartus, as well as a $33 million multiple-award Federal Supply Schedule contract covering Gilead's full pharmaceutical portfolio.

Quick answers

Who was awarded contract 36C26321N0248?

36C26321N0248 was awarded to Gilead Sciences Inc. by Veterans Integrated Service Network 23 (Veterans Health Administration) on November 9, 2020.

How much is contract 36C26321N0248 worth?

The government has obligated $81,743 on 36C26321N0248.

Is contract 36C26321N0248 an order under another contract?

Yes. 36C26321N0248 is a delivery order under V797D70252, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26321N0248 competed?

The extent of competition for 36C26321N0248 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award